AKR7A2
Basic information
Region (hg38): 1:19301991-19312144
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
- not_specified (57 variants)
- not_provided (1 variants)
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the AKR7A2 gene is commonly pathogenic or not. These statistics are base on transcript: NM_000003689.4. Only rare variants are included in the table.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Effect | PathogenicP | Likely pathogenicLP | VUSVUS | Likely benignLB | BenignB | Sum |
---|---|---|---|---|---|---|
synonymous | 0 | |||||
missense | 55 | 58 | ||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
Total | 0 | 0 | 55 | 2 | 1 |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
AKR7A2 | protein_coding | protein_coding | ENST00000235835 | 7 | 8182 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
1.99e-10 | 0.0688 | 125713 | 0 | 35 | 125748 | 0.000139 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | -0.417 | 211 | 195 | 1.08 | 0.0000117 | 2283 |
Missense in Polyphen | 69 | 60.752 | 1.1358 | 723 | ||
Synonymous | -0.854 | 99 | 88.8 | 1.12 | 0.00000605 | 730 |
Loss of Function | 0.0298 | 15 | 15.1 | 0.992 | 6.70e-7 | 180 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.000363 | 0.000363 |
Ashkenazi Jewish | 0.0000992 | 0.0000992 |
East Asian | 0.000224 | 0.000217 |
Finnish | 0.0000549 | 0.0000462 |
European (Non-Finnish) | 0.000142 | 0.000141 |
Middle Eastern | 0.000224 | 0.000217 |
South Asian | 0.0000980 | 0.0000980 |
Other | 0.000163 | 0.000163 |
dbNSFP
Source:
- Function
- FUNCTION: Catalyzes the NADPH-dependent reduction of succinic semialdehyde to gamma-hydroxybutyrate. May have an important role in producing the neuromodulator gamma-hydroxybutyrate (GHB). Has broad substrate specificity. Has NADPH-dependent aldehyde reductase activity towards 2-carboxybenzaldehyde, 2- nitrobenzaldehyde and pyridine-2-aldehyde (in vitro). Can reduce 1,2-naphthoquinone and 9,10-phenanthrenequinone (in vitro). Can reduce the dialdehyde protein-binding form of aflatoxin B1 (AFB1) to the non-binding AFB1 dialcohol. May be involved in protection of liver against the toxic and carcinogenic effects of AFB1, a potent hepatocarcinogen. {ECO:0000269|PubMed:17591773, ECO:0000269|PubMed:9576847}.;
- Pathway
- Metabolism of xenobiotics by cytochrome P450 - Homo sapiens (human);Aflatoxin B1 metabolism;Metapathway biotransformation Phase I and II;oxidative stress induced gene expression via nrf2;Biological oxidations;Metabolism;Aflatoxin activation and detoxification
(Consensus)
Intolerance Scores
- loftool
- 0.720
- rvis_EVS
- 0.71
- rvis_percentile_EVS
- 85.68
Haploinsufficiency Scores
- pHI
- 0.142
- hipred
- N
- hipred_score
- 0.148
- ghis
- 0.420
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.926
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Akr7a5
- Phenotype
Gene ontology
- Biological process
- carbohydrate metabolic process;cellular aldehyde metabolic process;xenobiotic metabolic process;electron transport chain;daunorubicin metabolic process;doxorubicin metabolic process
- Cellular component
- Golgi apparatus;cytosol;extracellular exosome
- Molecular function
- alditol:NADP+ 1-oxidoreductase activity;aldo-keto reductase (NADP) activity;protein binding;electron transfer activity;phenanthrene-9,10-epoxide hydrolase activity